Delivery Order SPE2DR25D7059-SPE2DR26F7NFX
- Not listed
- The Defense Logistics Agency awarded a $1,992.15 delivery order to AmerisourceBergen Drug Corp for ACT-O-Vials on December 10, 2025, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $13,283.20 to AmerisourceBergen Drug Corp for ACT-O-VIALS on November 25, 2025, with an ultimate completion date of November 26, 2025. This firm fixed-price delivery order was competitively awarded without any set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a $39,849.60 delivery order to AmerisourceBergen Drug Corp for ACT-O-VIALS on December 17, 2025, with an ultimate completion date of December 18, 2025. This non-set-aside contract employs firm fixed-price pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $9,298.24 firm fixed price delivery order to AmerisourceBergen Drug Corp for ACT-O-VIALS on December 22, 2025, with completion targeted for December 23, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $9,465.42 to AmerisourceBergen Drug Corp for Act-O-Vials on October 30, 2025, with completion expected by October 31, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The company will perform the work from its Corporate Office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,328.32 to AmerisourceBergen Drug Corp for ACT-O-VIALS on December 2, 2025, with an ultimate completion date of December 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The order will be fulfilled from the contractor's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,992.15 to AmerisourceBergen Drug Corp for Act-O-Vials on December 19, 2025, with an ultimate completion date of December 22, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation, indicating it was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $7,969.92 to AmerisourceBergen Drug Corp for ACT-O-VIALS on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The contract performs at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a $15,008.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for ACT-O-VIALS on November 19, 2025, with completion expected by November 20, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,968.60 firm fixed-price delivery order for ACT-O-VIALS with an ultimate completion date of December 22, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken,...
- SPE2DR25D7059Indefinite Delivery Contract
- SPE2DR25D7059-SPE2DR26F7NFXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,298.24 to AmerisourceBergen Drug Corp for ACT-O-VIALS on December 29, 2025, with an ultimate completion date of December 30, 2025. This firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical vendor for federal medical procurement through its comprehensive supply of pharmaceutical products and medical supplies to military and veteran healthcare systems. The company's extensive portfolio of DLA contract awards demonstrates its capability to fulfill diverse medical supply requirements, including specialty medications, vaccines, medical devices, and specialized healthcare commodities. This delivery order for ACT-O-VIALS supports the broader pharmaceutical supply needs of the Defense Health Agency and other federal healthcare systems served through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 12/28/25 |